Omnia Holdings boosted both revenue and profit in its year ending September 30, 2024, with sustained robust growth in its mining segment being a key driver of this positive momentum.
The group reported a 5% year-on-year boost in revenue to R10.9 billion ($614 million) in the 12-month period, alongside a 17% improvement in operating profit to R802 million.
On mining specifically – which, for Omnia, entails its BME business and the explosives, related accessories and blasting services offering – the company said: “The mining segment continued to demonstrate strong growth and robust performance. This growth was achieved through a combination of new and extended contracts, increased ammonia derivative sales, and new contract wins. Revenue increased by 15% to R4.7 billion while operating profit grew by 18% to R535 million. The segment effectively navigated global macroeconomic challenges and supply chain constraints to ensure uninterrupted supply to customers.”
The growth outlook for the group remains positive with solid traction gained in the reporting period, it noted.
The construction of an additional ammonium nitrate storage in Sasolburg will double storage capacity, further increasing supply chain flexibility and enabling consistent supply to customers.
The mining segment increased its momentum in its expansion efforts. Contract extensions and organic growth in the Southern African Development Community (SADC) region, as well as new contracts in Namibia, enhanced volumes in this core market.
In Indonesia three new contracts were successfully secured, signalling further growth in the region. While, in Canada, BME commissioned its non-electronic detonator manufacturing facility and the electric detonator manufacturing production line is due to be commissioned in the September quarter of 2025.
In the company’s 2026 financial year to September 30, 2026, BME in partnership with Hypex Bio, is set to launch a first of its kind nitrate free explosives to the Canadian market.
In 2023, Omnia announced a strategic partnership with Sweden-based Hypex Bio Explosives Technology and the acquisition of a minority equity stake in the company, looking to bring Hypex Bio’s ground-breaking emulsion, using hydrogen peroxide, offering to its customers.
In Australia, BME has commenced the building of its largest Mobile Manufacturing Units (MMU) with the first of these units expected to arrive towards the end of the 2025 financial year. Additionally, cold commissioning of Western Australia’s first electronic detonator plant has begun with production anticipated in the September quarter of 2025.
